Abstract
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention method, but it has been underutilized by women. Anticipated stigma regarding use of PrEP is a contributing factor in the underutilization of this prevention strategy. The current study explored the relationships among PrEP stigma, sex risk (i.e., inconsistent condom use, condomless sex with persons of unknown serostatus, or sex in exchange for money or drugs), substance use, attitudes toward HIV testing, and medical mistrust. Participants were 106 primarily ethnic-minority women who reported recent substance use and agreed to participate in a study exploring HIV prevention attitudes. Within this sample, the majority of participants had one or more CDC-defined PrEP indications. Findings indicate that medical mistrust was associated with perceived PrEP stereotypes and HIV testing attitudes. These results provide some insight into reasons for low PrEP uptake among women at risk for HIV. Implications for HIV prevention with women are discussed.
Similar content being viewed by others
References
Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015). Knowledge, attitudes and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care and STDs, 29(2), 102–110. https://doi.org/10.1089/apc.2014.0142
Boshamer, C. B., & Bruce, K. E. (1999). A scale to measure attitudes about HIV-antibody testing: Development and psychometric validation. AIDS Education and Prevention, 11(5), 400–413.
Calabrese, K. S., Dovidio, F. J., Tekeste, W. M., Taggart, B. T., Galvao, C. R., Safon, S. C., Willie, S. T., Caldwell, S. A., Kaplan, S. C., & Kershaw, S. T. (2018). HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend Planned Parenthood. JAIDS Journal of Acquired Immune Deficiency Syndromes, 79(1), 46–53. https://doi.org/10.1097/QAI.0000000000001762
Calabrese, S. K., Earnshaw, V. A., Underhill, K., Hansen, N. B., & Dovidio, J. F. (2014). The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): Assumptions about sexual risk compensation and implications for access. AIDS and Behavior, 18(2), 226–240. https://doi.org/10.1007/s10461-013-0675-x
Carley, T., Siewert, E., & Naresh, A. (2019). Interest in pre-exposure prophylaxis (PrEP) for HIV is limited among women in a general obstetrics & gynecology setting. AIDS and Behavior, 23(10), 2741–2748. https://doi.org/10.1007/s10461-019-02529-1
CDC. (2019a). Estimated HIV incidence and prevalence in the United States, 2010–2016 (HIV Surveillance Supplemental Report 2019, Issue. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
CDC. (2019b). HIV surveillance report, 2018 (Preliminary); vol.30. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
CDC. ( 2019c). CDC data confirm: Progress in HIV prevention has stalled https://www.cdc.gov/media/releases/2019/0227-hiv-prevention-stalled.html#:~:text=The%20dramatic%20decline%20in%20annual,America%20from%202010%20to%202016.
Colfax, G., & Shoptaw, S. (2005). The methamphetamine epidemic: Implications for HIV prevention and treatment. Current HIV/AIDS Reports, 2(4), 194–199
Dovidio, J. F., Penner, L. A., Albrecht, T. L., Norton, W. E., Gaertner, S. L., & Shelton, J. N. (2008). Disparities and distrust: The implications of psychological processes for understanding racial disparities in health and health care. Social Science & Medicine. 67(3), 478–486. https://doi.org/10.1016/j.socscimed.2008.03.019
Eaton, L. A., Kalichman, S. C., Price, D., Finneran, S., Allen, A., & Maksut, J. (2017). Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among Black and White men and transgender women who have sex with men. AIDS and Behavior, 21(5), 1236–1246. https://doi.org/10.1007/s10461-017-1690-0
Farhat, D., Greene, E., Paige, M. Q., Koblin, B. A., & Frye, V. (2017). Knowledge, stereotyped beliefs and attitudes around HIV chemoprophylaxis in two high HIV prevalence neighborhoods in New York City. AIDS and Behavior, 21(5), 1247–1255. https://doi.org/10.1007/s10461-016-1426-6
Fauci, A. S., Redfield, R. R., Sigounas, G., Weahkee, M. D., & Giroir, B. P. (2019). Ending the HIV epidemic: A plan for the United States. Journal of the American Medical Association, 321(9), 844–845. https://doi.org/10.1001/jama.2019.1343
Galea, J. T., Kinsler, J. J., Salazar, X., Lee, S. J., Giron, M., Sayles, J. N., Cáceres, C., & Cunningham, W. E. (2011). Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: Barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. International Journal of STD & AIDS, 22(5), 256–262. https://doi.org/10.1258/ijsa.2009.009255
Goffman, E. (2009). Stigma: Notes on the management of spoiled identity. Simon and Schuster.
Golub, S. A., Gamarel, K. E., & Surace, A. (2015). Demographic differences in PrEP-related stereotypes: Implications for implementation. AIDS and Behavior, 21(5), 1229–1235. https://doi.org/10.1007/s10461-015-1129-4
Goparaju, L., Praschan, N. C., Warren-Jeanpiere, L., Experton, L. S., Young, M. A., & Kassaye, S. (2017). Stigma, partners, providers and costs: Potential barriers to PrEP uptake among US women. Journal of AIDS & Clinical Research, 8(9). https://doi.org/10.4172/2155-6113.1000730
Harris, N. S., Johnson, A. S., Huang, Y.-L. A., Kern, D., Fulton, P., Smith, D. K., Valleroy, L. A., & Hall, H. I. (2019). Vital signs: Status of human immunodeficiency virus testing, viral suppression and HIV preexposure prophylaxis-United States, 2013–2018. MMWR. Morbidity and Mortality Weekly Report, 68(48), 1117–1123. https://doi.org/10.15585/mmwr.mm6848e1
Hoyt, M. A., Rubin, L. R., Nemeroff, C. J., Lee, J., Huebner, D. M., & Proeschold-Bell, R. J. (2012). HIV/AIDS-related institutional mistrust among multiethnic men who have sex with men: Effects on HIV testing and risk behaviors. Health Psychology, 31(3), 269–277. https://doi.org/10.1037/a0025953
Hunter, B. A., Jason, L. A., & Keys, C. B. (2013). Factors of empowerment for women in recovery from substance use. American Journal of Community Psychology, 51(1–2), 91–102. https://doi.org/10.1007/s10464-012-9499-5
Kelley, C. F., Kahle, E., Siegler, A., Sanchez, T., Del Rio, C., Sullivan, P. S., & Rosenberg, E. S. (2015). Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clinical Infectious Diseases, 61(10), 1590–1597. https://doi.org/10.1093/cid/civ664
Kelly, J. A., Somlai, A. M., DiFranceisco, W. J., Otto-Salaj, L. L., McAuliffe, T. L., Hackl, K. L., Heckman, T. G., Holtgrave, D. R., & Rompa, D. (2000). Bridging the gap between the science and service of HIV prevention: Transferring effective research-based HIV prevention interventions to community AIDS service providers. American Journal of Public Health, 90(7), 1082–1088. https://doi.org/10.2105/AJPH.90.7.1082
Kerrigan, D., Mantsios, A., Grant, R., Markowitz, M., Defechereux, P., La Mar, M., Beckham, S., Hammond, P., Margolis, D., & Murray, M. (2018). Expanding the menu of HIV prevention options: A qualitative study of experiences with long-acting injectable cabotegravir as PrEP in the context of a phase II trial in the United States. AIDS and Behavior, 22(11), 3540–3549
Krakower, D., & Mayer, K. H. (2012). Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Current Opinion in HIV and AIDS, 7(6), 593–599. https://doi.org/10.1097/COH.0b013e3283590446
Krakower, D., Ware, N., Mitty, J. A., Maloney, K., & Mayer, K. H. (2014). HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: A qualitative study. AIDS and Behavior, 18(9), 1712–1721
Loflin, M., Babson, K., Browne, K., & Bonn-Miller, M. (2018). Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users. American Journal of Drug and Alcohol Abuse, 44(1), 19–23. https://doi.org/10.1080/00952990.2017.1376677
Maguiña, J. L., Konda, K. A., Leon, S. R., Lescano, A. G., Clark, J. L., Hall, E. R., Klausner, J. D., Coates, T. J., & Caceres, C. F. (2013). Relationship between alcohol consumption prior to sex, unprotected sex and prevalence of STI/HIV among socially marginalized men in three coastal cities of Peru. AIDS and Behavior, 17(5), 1724–1733
Metzger, D., Woody, G., Navaline, H., McLellan, A., Meyers, K., Boney, T., Mulvaney, F., Williams, J., Dyanick, S., & Jonson, A. (1993). The Risk Assessment Battery (RAB): Validity and reliability. Sixth Annual Meeting of National Cooperative Vaccine Development Group for AIDS.
Murray, M. I., Markowitz, M., Frank, I., Grant, R. M., Mayer, K. H., Hudson, K. J., Stancil, B. S., Ford, S. L., Patel, P., & Rinehart, A. R. (2018). Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial. HIV Clinical Trials, 19(4), 129–138
Mustanski, B., Ryan, D. T., Hayford, C., Phillips, G., Newcomb, M. E., & Smith, J. D. (2018). Geographic and individual associations with PrEP stigma: Results from the RADAR cohort of diverse young men who have sex with men and transgender women. AIDS and Behavior, 22(9), 3044–3056. https://doi.org/10.1007/s10461-018-2159-5
Philbin, M. M., Parish, C., Kinnard, E. N., Reed, S. E., Kerrigan, D., Alcaide, M. L., Cohen, M. H., Sosanya, O., Sheth, A. N., Adimora, A. A., Cocohoba, J., Goparaju, L., Golub, E. T., Fischl, M., & Metsch, L. R. (2021). Interest in long-acting injectable pre-exposure prophylaxis (LAI PrEP) among women in the Women’s Interagency HIV Study (WIHS): A qualitative study across six cities in the United States. AIDS and Behavior, 25(3), 667–678. https://doi.org/10.1007/s10461-020-03023-9
Raifman, G. J., & Sherman, G. S. (2018). U.S. guidelines that empower women to prevent HIV with pre-exposure prophylaxis: Women and PrEP guidelines. Sexually Transmitted Diseases, 45(6), e38–e39. https://doi.org/10.1097/OLQ.0000000000000811
Raj, A., Saitz, R., Cheng, D. M., Winter, M., & Samet, J. H. (2007). Associations between alcohol, heroin and cocaine use and high risk sexual behaviors among detoxification patients. American Journal of Drug and Alcohol Abuse, 33(1), 169–178
Reid, A. E., Dovidio, J. F., Ballester, E., & Johnson, B. T. (2014). HIV prevention interventions to reduce sexual risk for African Americans: The influence of community-level stigma and psychological processes. Social Science & Medicine, 103, 118–125. https://doi.org/10.1016/j.socscimed.2013.06.028
Saunders, J. B., Aasland, O. G., Babor, T. F., De La Fuente, J. R., & Grant, M. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction, 88(6), 791–804. https://doi.org/10.1111/j.1360-0443.1993.tb02093.x
Sheth, A. N., Rolle, C. P., & Gandhi, M. (2016). HIV pre-exposure prophylaxis for women. Journal of Virus Eradication, 2(3), 149–155. https://pubmed.ncbi.nlm.nih.gov/27482454
Smith, D. K., Toledo, L., Smith, D. J., Adams, M. A., & Rothenberg, R. (2012). Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Education and Prevention, 24(5), 408–421. https://doi.org/10.1521/aeap.2012.24.5.408
Thompson, H. S., Valdimarsdottir, H. B., Winkel, G., Jandorf, L., & Redd, W. (2004). The Group-Based Medical Mistrust Scale: Psychometric properties and association with breast cancer screening. Preventive Medicine, 38(2), 209–218. https://doi.org/10.1016/j.ypmed.2003.09.041
Wechsberg, W. M., Lam, W. K., Zule, W. A., & Bobashev, G. (2004). Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. American Journal of Public Health, 94(7), 1165–1173
Wingood, G. M., Dunkle, K., Camp, C., Patel, S., Painter, J. E., Rubtsova, A., & DiClemente, R. J. (2013). Racial differences and correlates of potential adoption of preexposure prophylaxis: Results of a national survey. JAIDS Journal of Acquired Immune Deficiency Syndromes, 63, S95–S101. https://doi.org/10.1097/QAI.0b013e3182920126
Funding
This project was partially supported by a grant from the Substance Abuse and Mental. Health Services Administration (SAMHSA) H79TI080734 (PI: Heads). The content is solely the. responsibility of the authors and does not necessarily represent the official views of SAMHSA.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest. The lead author’s work was supported in part by the Substance Abuse and Mental Health Services Administration (SAMHSA) Grant H79TI080734. The content is solely the responsibility of the authors and does not necessarily represent the official views of SAMHSA.
Ethical Approval
All procedures were performed in accordance with the ethical standards of institutional review board (UTHealth McGovern Medical School Committee on the Protection of Human Subjects Institutional Review Board Protocol # HSC-MS-19–0585 and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Heads, A.M., Hill, M.J., Suchting, R. et al. Predictors of Anticipated PrEP Stigma among Women with Self-Reported Problematic Substance Use: Implications for Engaging Women in the PrEP Care Continuum. Arch Sex Behav 50, 2955–2964 (2021). https://doi.org/10.1007/s10508-021-02031-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10508-021-02031-7